Australia is closely awaiting the arrival of retatrutide, a novel dual GIP and GLP-1 receptor agonist that's generating significant buzz in the global weight management landscape. Developed by Novo Nordisk, this https://nanauuef969280.wikimillions.com/583400/this_new_drug_retatrutide_australia_a_promising_solution_for_obesity_treatment